SH3GL2 and cancer: Interestingly, due to less common occurrence in other cancer types, larger differences in expression rates in GBM than the normal tissue three genes, namely, CACNA1E, DDN, and SH3GL2, Figure 8 can be proposed as potential prognostic biomarkers of GBM.